BioPharm Solutions

Bio-Pharm Solutions (B-PS) is a new drug developer focused on central nervous system (CNS) and rare diseases. It is a rapidly growing company aiming to become a specialized pharmaceutical company in the global market. Bio-Pharm Solutions is developing new drugs that meet global standards and conducting global clinical trials approved by the U.S. FDA and EMA alongside its CEO, who has successfully developed multiple global new drugs, playing a core role from the discovery stage through clinical trials.Through joint research with the U.S. National Institutes of Health (NIH) and collaboration with a global expert advisory network, the company’s first epilepsy drug, JBPOS0101, received Investigational New Drug (IND) approval from the U.S. FDA in 2013. The company began developing new drugs five years after its establishment.